IntelGenx Technologies Corp. (IGXT)
OTCMKTS
· Delayed Price · Currency is USD
0.167
-0.006 (-3.75%)
At close: May 16, 2024
IntelGenx Technologies Revenue
IntelGenx Technologies had revenue of $174.00K in the quarter ending March 31, 2024, with 7.41% growth. This brings the company's revenue in the last twelve months to $1.05M, up 20.11% year-over-year. In the year 2023, IntelGenx Technologies had annual revenue of $1.04M with 9.37% growth.
Revenue (ttm)
1.05M
Revenue Growth
+20.11%
P/S Ratio
27.75
Revenue / Employee
21.02K
Employees
50
Market Cap
29.17M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.04M | 89.00K | 9.37% |
Dec 31, 2022 | 950.00K | -585.00K | -38.11% |
Dec 31, 2021 | 1.54M | -9.00K | -0.58% |
Dec 31, 2020 | 1.54M | 802.00K | 108.09% |
Dec 31, 2019 | 742.00K | -1.08M | -59.32% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 920.97M |
Medexus Pharmaceuticals Inc. | 108.78M |